| mesonephric duct formation | GO:0072181 | 2 | 0.118 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.108 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.097 | |
| microtubule based process | GO:0007017 | 236 | 0.092 | |
| transmembrane transport | GO:0055085 | 412 | 0.087 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.084 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.079 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.075 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.062 | |
| male gamete generation | GO:0048232 | 285 | 0.061 | |
| lung induction | GO:0060492 | 3 | 0.060 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.060 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.058 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.056 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.055 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.055 | |
| germ cell development | GO:0007281 | 185 | 0.053 | |
| kidney development | GO:0001822 | 213 | 0.052 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.051 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.050 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.049 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.049 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.049 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.048 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.045 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.045 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.044 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.044 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.043 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.043 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.043 | |
| protein ubiquitination | GO:0016567 | 171 | 0.041 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.041 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.041 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.041 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.040 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.040 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.040 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.039 | |
| spermatogenesis | GO:0007283 | 284 | 0.039 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.039 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.039 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.038 | |
| nephric duct formation | GO:0072179 | 4 | 0.037 | |
| cell cell junction organization | GO:0045216 | 72 | 0.037 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.036 | |
| leukocyte migration | GO:0050900 | 124 | 0.036 | |
| endomembrane system organization | GO:0010256 | 147 | 0.036 | |
| regionalization | GO:0003002 | 337 | 0.035 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.034 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.034 | |
| cation transport | GO:0006812 | 399 | 0.034 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.034 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.034 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.033 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.033 | |
| calcium independent cell cell adhesion via plasma membrane cell adhesion molecules | GO:0016338 | 4 | 0.032 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.032 | |
| interleukin 8 production | GO:0032637 | 4 | 0.032 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.031 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.031 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.031 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.030 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.030 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.030 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.030 | |
| organelle localization | GO:0051640 | 179 | 0.029 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.029 | |
| renal outer medulla development | GO:0072054 | 2 | 0.029 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.029 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.028 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.028 | |
| cell junction organization | GO:0034330 | 77 | 0.028 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.028 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.028 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.028 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.028 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.028 | |
| interleukin 6 production | GO:0032635 | 58 | 0.027 | |
| cell cell junction assembly | GO:0007043 | 27 | 0.027 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.027 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.027 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.027 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.027 | |
| response to starvation | GO:0042594 | 65 | 0.027 | |
| regulation of anagen | GO:0051884 | 1 | 0.027 | |
| negative regulation of meiotic cell cycle phase transition | GO:1901994 | 3 | 0.027 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.027 | |
| lipid transport | GO:0006869 | 98 | 0.027 | |
| mapk cascade | GO:0000165 | 281 | 0.026 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.026 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.026 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.026 | |
| neuronal action potential | GO:0019228 | 54 | 0.026 | |
| hindbrain formation | GO:0021576 | 1 | 0.026 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.026 | |
| sodium ion transport | GO:0006814 | 73 | 0.025 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.025 | |
| response to oxidative stress | GO:0006979 | 123 | 0.025 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.025 | |
| cellular homeostasis | GO:0019725 | 240 | 0.025 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.025 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.025 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.025 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.025 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.024 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.024 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.024 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.024 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.024 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.024 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.024 | |
| inflammatory response | GO:0006954 | 244 | 0.024 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.024 | |
| regulation of microtubule based process | GO:0032886 | 52 | 0.024 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.024 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.024 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.024 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.023 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.023 | |
| skin development | GO:0043588 | 220 | 0.023 | |
| skeletal system development | GO:0001501 | 356 | 0.023 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.023 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.023 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.023 | |
| cell division | GO:0051301 | 120 | 0.023 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.023 | |
| body fluid secretion | GO:0007589 | 53 | 0.022 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.022 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.022 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.022 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.021 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.021 | |
| proton transport | GO:0015992 | 35 | 0.021 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.021 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.021 | |
| exocytosis | GO:0006887 | 121 | 0.021 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.021 | |
| cell junction assembly | GO:0034329 | 52 | 0.021 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.021 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.021 | |
| axon ensheathment | GO:0008366 | 76 | 0.021 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.021 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.021 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.020 | |
| regulation of cell motility | GO:2000145 | 236 | 0.020 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.020 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.020 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.020 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.020 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.020 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.020 | |
| digestive tract development | GO:0048565 | 190 | 0.020 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.020 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.020 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.020 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.020 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.020 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.020 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.019 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.019 | |
| actin filament organization | GO:0007015 | 113 | 0.019 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.019 | |
| spemann organizer formation | GO:0060061 | 2 | 0.019 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.019 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.019 | |
| positive regulation of t cell anergy | GO:0002669 | 4 | 0.019 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.019 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.019 | |
| endocytosis | GO:0006897 | 168 | 0.019 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.019 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.019 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.019 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.019 | |
| detection of molecule of bacterial origin | GO:0032490 | 2 | 0.019 | |
| fat cell differentiation | GO:0045444 | 160 | 0.019 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.019 | |
| epithelial cell migration | GO:0010631 | 63 | 0.018 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.018 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.018 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.018 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.018 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.018 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.018 | |
| t cell activation | GO:0042110 | 289 | 0.018 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.018 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.018 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.018 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.018 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.018 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.018 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.018 | |
| oviduct development | GO:0060066 | 3 | 0.018 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.018 | |
| cell cell adhesion | GO:0098609 | 41 | 0.018 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.017 | |
| regulation of ph | GO:0006885 | 26 | 0.017 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.017 | |
| sphingolipid biosynthetic process | GO:0030148 | 26 | 0.017 | |
| cell cycle switching | GO:0060184 | 1 | 0.017 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.017 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.017 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.017 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.017 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.017 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.017 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.017 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.017 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.017 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.017 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.016 | |
| protein catabolic process | GO:0030163 | 221 | 0.016 | |
| organelle fission | GO:0048285 | 170 | 0.016 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.016 | |
| action potential | GO:0001508 | 78 | 0.016 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.016 | |
| positive regulation of protein modification by small protein conjugation or removal | GO:1903322 | 30 | 0.016 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.016 | |
| plasma membrane organization | GO:0007009 | 90 | 0.016 | |
| epithelial cell development | GO:0002064 | 159 | 0.016 | |
| protein maturation | GO:0051604 | 176 | 0.016 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.016 | |
| peptidyl threonine phosphorylation | GO:0018107 | 31 | 0.016 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.016 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.016 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.016 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.016 | |
| response to fructose | GO:0009750 | 2 | 0.016 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.016 | |
| lung field specification | GO:0060424 | 3 | 0.016 | |
| digestion | GO:0007586 | 40 | 0.016 | |
| maintenance of cell number | GO:0098727 | 3 | 0.016 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.016 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.016 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.016 | |
| positive regulation of meiotic cell cycle | GO:0051446 | 15 | 0.015 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.015 | |
| hair cycle phase | GO:0044851 | 16 | 0.015 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.015 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.015 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.015 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.015 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.015 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.015 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.015 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.015 | |
| regulation of protein tyrosine kinase activity | GO:0061097 | 17 | 0.015 | |
| regulation of secretion | GO:0051046 | 274 | 0.015 | |
| regulation of transposition | GO:0010528 | 2 | 0.015 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.015 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.015 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.015 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.015 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.015 | |
| urogenital system development | GO:0001655 | 261 | 0.015 | |
| lateral inhibition | GO:0046331 | 1 | 0.015 | |
| connective tissue development | GO:0061448 | 179 | 0.015 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.014 | |
| maintenance of location | GO:0051235 | 89 | 0.014 | |
| cellular response to lipid | GO:0071396 | 145 | 0.014 | |
| regulation of cell size | GO:0008361 | 72 | 0.014 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.014 | |
| renal inner medulla development | GO:0072053 | 3 | 0.014 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.014 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.014 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.014 | |
| trabecula formation | GO:0060343 | 24 | 0.014 | |
| angiogenesis | GO:0001525 | 201 | 0.014 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.014 | |
| foregut regionalization | GO:0060423 | 3 | 0.014 | |
| mesenchymal cell apoptotic process involved in metanephros development | GO:1900200 | 4 | 0.014 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.014 | |
| cell fate commitment | GO:0045165 | 210 | 0.013 | |
| defense response to bacterium | GO:0042742 | 119 | 0.013 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.013 | |
| lung development | GO:0030324 | 164 | 0.013 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.013 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.013 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.013 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.013 | |
| negative regulation of stem cell maintenance | GO:1902455 | 4 | 0.013 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.013 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.013 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.013 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.013 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.013 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.013 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.013 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.013 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.013 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.013 | |
| response to inorganic substance | GO:0010035 | 96 | 0.013 | |
| hydrogen ion transmembrane transport | GO:1902600 | 25 | 0.013 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.013 | |
| digestive system development | GO:0055123 | 200 | 0.013 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.013 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.013 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.012 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.012 | |
| germline cell cycle switching mitotic to meiotic cell cycle | GO:0051729 | 1 | 0.012 | |
| cerebellum formation | GO:0021588 | 1 | 0.012 | |
| renal system development | GO:0072001 | 225 | 0.012 | |
| biological phase | GO:0044848 | 20 | 0.012 | |
| negative regulation of protein tyrosine kinase activity | GO:0061099 | 3 | 0.012 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.012 | |
| cell adhesion | GO:0007155 | 329 | 0.012 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.012 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.012 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.012 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.012 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.012 | |
| microtubule based movement | GO:0007018 | 84 | 0.012 | |
| energy coupled proton transmembrane transport against electrochemical gradient | GO:0015988 | 3 | 0.012 | |
| positive regulation of cilium movement | GO:0003353 | 1 | 0.012 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.012 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.012 | |
| regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900211 | 4 | 0.012 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.012 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.012 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.012 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.012 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.012 | |
| mesonephric duct development | GO:0072177 | 5 | 0.012 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.012 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.011 | |
| developmental maturation | GO:0021700 | 193 | 0.011 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.011 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.011 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.011 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.011 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.011 | |
| apical junction assembly | GO:0043297 | 15 | 0.011 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.011 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.011 | |
| wound healing | GO:0042060 | 157 | 0.011 | |
| nuclear division | GO:0000280 | 158 | 0.011 | |
| potassium ion transport | GO:0006813 | 52 | 0.011 | |
| cytokine production | GO:0001816 | 319 | 0.011 | |
| biomineral tissue development | GO:0031214 | 64 | 0.011 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.011 | |
| regulation of cell migration | GO:0030334 | 219 | 0.011 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.011 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.011 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.011 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.011 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.011 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.011 | |
| negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072040 | 4 | 0.011 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.011 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.011 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.011 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.011 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.011 | |
| rna processing | GO:0006396 | 105 | 0.010 | |
| jnk cascade | GO:0007254 | 72 | 0.010 | |
| epithelial tube formation | GO:0072175 | 130 | 0.010 | |
| regulation of cell division | GO:0051302 | 76 | 0.010 | |
| membrane organization | GO:0061024 | 245 | 0.010 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.010 | |
| hydrogen transport | GO:0006818 | 35 | 0.010 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.010 | |
| sensory perception of taste | GO:0050909 | 18 | 0.010 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.010 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.010 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.010 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.010 | |
| tube formation | GO:0035148 | 140 | 0.010 | |
| ossification | GO:0001503 | 216 | 0.010 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.010 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.010 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.010 | |
| t cell differentiation | GO:0030217 | 174 | 0.010 | |
| germ line sex determination | GO:0018992 | 3 | 0.010 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.010 | |
| placenta development | GO:0001890 | 140 | 0.010 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.010 | |
| embryonic placenta development | GO:0001892 | 98 | 0.010 | |
| cilium movement | GO:0003341 | 28 | 0.010 | |
| amine metabolic process | GO:0009308 | 45 | 0.010 | |
| epithelium migration | GO:0090132 | 63 | 0.010 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.010 | |
